Page last updated: 2024-12-05

didecyldimethylammonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Didecyldimethylammonium is a quaternary ammonium compound. It is a colorless or pale yellow liquid with a mild odor. It is used as a cationic surfactant in a variety of applications, including antimicrobial agents, fabric softeners, and hair conditioners. The compound is synthesized by reacting dimethylamine with a mixture of decyl alcohols. It has been studied for its antimicrobial properties, which are due to its ability to disrupt cell membranes. Its effects on the environment are of concern due to its potential to disrupt aquatic ecosystems. It is important to study this compound due to its widespread use in various industries and its potential environmental impact.'

didecyldimethylammonium: RN given refers to parent cpd; deciquam 222 refers to bromide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16958
CHEMBL ID1182247
CHEBI ID193591
SCHEMBL ID29931
MeSH IDM0088420

Synonyms (33)

Synonym
BIDD:ER0612
CHEMBL1182247
didecyl-dimethyl-ammonium
deciquam 222
ammonium, didecyldimethyl-
20256-56-8
10A ,
1-decanaminium, n-decyl-n,n-dimethyl-
ammonium, didecyldimethyl- (8ci)
1-decanaminium, n-decyl-n,n-dimethyl- (9ci)
DB04221
didecyldimethylammonium cation
didecyldimethylammonium
didecyldimethylammonium ion
didecyldimonium
didecyl(dimethyl)azanium bromide
didecyl(dimethyl)azanium
CHEBI:193591
NCGC00166066-03
NCGC00166066-02
unii-z7f472xqpa
z7f472xqpa ,
didecyldimonium cation
didecyldimethylammonium [who-dd]
didecyldimonium ion
JGFDZZLUDWMUQH-UHFFFAOYSA-N
SCHEMBL29931
DTXSID0048004 ,
didecyldimethylammoniumchloride
n-decyl-n,n-dimethyldecan-1-aminium
Q27095047
dtxcid0027981
meoly milia remover serum

Research Excerpts

Overview

Didecyldimethylammonium chloride is an active substance used for disinfection and antisepsis. It is used in the medical area as well as in the food, industrial and institutional area.

ExcerptReferenceRelevance
"Didecyldimethylammonium chloride is an active substance which is part of variety of formulations used for the disinfection and antisepsis, both in the medical area as well as in the food, industrial and institutional area. "( Susceptibility of selected strains used for evaluation of biocidal efficiency of disinfectants and antibiotic-resistant strains to didecyldimethylammonium chloride in 2-propanol.
Chojecka, A; Jakimiak, B; Kanclerski, K; Röhm-Rodowald, E; Wiercińska, O, 2015
)
2.06

Toxicity

ExcerptReferenceRelevance
" The purpose of this study was to evaluate the toxic interaction between DDAC and EG in the lung."( Acute pulmonary toxicity and inflammation induced by combined exposure to didecyldimethylammonium chloride and ethylene glycol in rats.
Choi, K; Kim, E; Kim, HM; Kim, P; Kwon, do Y; Kwon, JT; Lim, YM, 2016
)
0.67

Compound-Compound Interactions

ExcerptReferenceRelevance
" Hoe S 2922) in combination with the steroid prednicarbate (prednisolone 17-(ethylcarbonate)-21-propionate, Hoe 777) were used."( [Treatment of impetiginized eczema with prednicarbate in combination with a quarternary ammonium salt].
Schäfer, V; Wölbling, RH, 1987
)
0.27

Bioavailability

ExcerptReferenceRelevance
" The main factor impeding the biodegradation of dialkyldimethylammonium salts with long alkyl chains is probably the low bioavailability of water-insoluble chemicals."( Assessment of the biodegradability of dialkyldimethylammonium salts in flow through systems.
Geurts, MG; Hoenderboom, A; van Ginkel, CG; van Haperen, AM, 2003
)
0.32
"The toxicity of the dialkyl quat, didecyldimethylammonium bromide (DDAB), was used as a typical quaternary ammonium compound in studies investigating the role of sorption in reducing DDAB bioavailability in sediment and soil for natural and artificial substrates."( Bioavailability and detoxification of cationics: II. Relationship between toxicity and CEC of cationic surfactants on Caenorhabditis elegans (Nematoda) in artificial and natural substrates.
Geurts, M; Thomas, PC; van Wijk, D; Velthoven, K, 2009
)
0.63
" Both DDAC and C12-C16 ADBAC are poorly absorbed via the oral and dermal exposure routes (≤10%), are not systemically distributed, and are primarily excreted in feces."( Human health hazard assessment of quaternary ammonium compounds: Didecyl dimethyl ammonium chloride and alkyl (C12-C16) dimethyl benzyl ammonium chloride.
DeLeo, P; Freemantle, M; Luz, A; Pechacek, N, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
" Multiple dosing of DDAC increased its flux across the skin, when applied in high concentrations (>11 mg/mL)."( Dermatokinetics of didecyldimethylammonium chloride and the influence of some commercial biocidal formulations on its dermal absorption in vitro.
Buist, HE; de Heer, C; van Burgsteden, JA; van de Sandt, JJ, 2007
)
0.67
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
quaternary ammonium saltDerivatives of ammonium compounds, (NH4(+))Y(-), in which all four of the hydrogens bonded to nitrogen have been replaced with univalent (usually organyl) groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
phosphopantetheinyl transferaseBacillus subtilisPotency56.23410.141337.9142100.0000AID1490
USP1 protein, partialHomo sapiens (human)Potency31.62280.031637.5844354.8130AID504865
GLS proteinHomo sapiens (human)Potency31.62280.35487.935539.8107AID624170
huntingtin isoform 2Homo sapiens (human)Potency11.22020.000618.41981,122.0200AID1688
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency22.38720.00798.23321,122.0200AID2546
gemininHomo sapiens (human)Potency5.95690.004611.374133.4983AID624296
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency20.61820.005612.367736.1254AID624032; AID624044
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency35.48130.060110.745337.9330AID492961
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (95)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (5.26)18.7374
1990's7 (7.37)18.2507
2000's25 (26.32)29.6817
2010's44 (46.32)24.3611
2020's14 (14.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 57.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index57.14 (24.57)
Research Supply Index4.65 (2.92)
Research Growth Index5.05 (4.65)
Search Engine Demand Index93.03 (26.88)
Search Engine Supply Index2.03 (0.95)

This Compound (57.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (2.97%)5.53%
Reviews3 (2.97%)6.00%
Case Studies4 (3.96%)4.05%
Observational0 (0.00%)0.25%
Other91 (90.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]